Marina Díaz-Beyá

7PUBLICATIONS
40CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematological tumoursMedical mycologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2025
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.

Jose R Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez

|May 29, 2024
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.

Carlos Jiménez-Vicente, Paola Charry, Sandra Castaño-Diez

|Feb 27, 2024
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.

Adrian Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas Diaz Varela

|Nov 28, 2023
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.

Sandra Castaño-Díez, Helena Pomares, Daniel Esteban

|Jun 09, 2020
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

Alex Bataller, Guadalupe Oñate, Marina Diaz-Beyá

|Feb 06, 2020
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.

Marina Díaz-Beyá, Myriam Labopin, Johan Maertens

Pageof 2

Frequent Collaborators

5 joint publications

Jordi Esteve

3 joint publications

Carlos Jiménez-Vicente

2 joint publications

Blanca Xicoy Cirici

2 joint publications

Jorge Sierra